Chee-Keng Ng

Analytical Ops/CMC Contract Consultant at Akero Therapeutics - South San Francisco, CA, US

Chee-Keng Ng's Colleagues at Akero Therapeutics
Erik PhD

Principal Scientist

Contact Erik PhD

William White

CFO and Head of Corporate Development

Contact William White

Arindam Bose

Vice President, Process Development

Contact Arindam Bose

Timothy Rolph

Chief Scientific Officer

Contact Timothy Rolph

View All Chee-Keng Ng's Colleagues
Chee-Keng Ng's Contact Details
HQ
650-487-6488
Location
Company
Akero Therapeutics
Chee-Keng Ng's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Chee-Keng Ng
Chee-Keng Ng currently works for Akero Therapeutics.
Chee-Keng Ng's role at Akero Therapeutics is Analytical Ops/CMC Contract Consultant.
Chee-Keng Ng's email address is ***@akerotx.com. To view Chee-Keng Ng's full email address, please signup to ConnectPlex.
Chee-Keng Ng works in the Biotechnology industry.
Chee-Keng Ng's colleagues at Akero Therapeutics are Erik PhD, Andrea Canavero, William White, Arindam Bose, Mark Iwicki, Thomas Quinn, Timothy Rolph and others.
Chee-Keng Ng's phone number is 650-487-6488
See more information about Chee-Keng Ng